DCIS
More than 90% of the cases entered into the Sloane Project are of DCIS. This page gives relevant extracts from the Sloane Pathology Form,
examples of the main patterns seen in your practice and also some side-by-side images to act as an aide memoire
for grading. There will always be an element of subjectivity at the grade 'boundaries' but it is hoped that we can help reduce
the inter-observer variability by providing guidance notes and high quality images to illustrate the points.
Growth Pattern
Grading
Paget's Disease of the Nipple
Microinvasion
Assessing receptor status in DCIS
The Sloane Project Steering Group has also arranged for a number of good examples of DCIS cases to be rendered as whole slide scans
so that you can explore the range of features present. These are avilable on..... Link to Digital Slide Box - via Sloane Project website.
Growth Pattern
Solid DCIS (example 1)
 |
 |
Cribriform DCIS (example 1)
 |
 |
Cribriform DCIS (example 2)
 |
 |
Cribriform DCIS (example 2)
 |
Micropapillary DCIS (example 1)
 |
 |
Papillary DCIS (intracystic papillary carcinoma) (example 1 - macro)
 |
Papillary DCIS (intracystic papillary carcinoma) (example 1)
 |
 |
Apocrine DCIS (example 1)
 |
 |
Apocrine DCIS (example 2)
 |
 |
Clinging DCIS (example 1)
 |
 |
Clinging/Flat DCIS (example 2)
 |
 |
Grading
College of American Pathologists Guidelines for grading DCIS:
- Grade 1:
- Monotonous nuclei, 1.5 to 2.0 RBC diameters
- finely dispersed chromatin & only occasional nucleoli
- Grade 2:
- Neither nuclear grade 1 nor nuclear grade 3
- Grade 3:
- Markedly pleomorphic nuclei, usually greater than 2.5 RBC diameters
- coarse chromatin & prominent or multiple nucleoli
In the following series of six combination photos all the images have been photographed using a x40
objective on the same microscope. Every effort has been made to ensure that during the assembly of the images the magnifications remain
comparable and unaltered.
Grading DCIS - Combination photo showing three separate examples of low grade DCIS
 |
Grading DCIS - Combination photo showing three separate examples of intermediate grade DCIS
 |
Grading DCIS - Combination photo showing three separate examples of high grade DCIS
 |
Grading DCIS - Low grade left hand panel, high grade right hand panel
 |
Grading DCIS (Micropapillary DCIS) - Low grade left hand panel, high grade right hand panel
 |
Grading DCIS - Low grade left hand panel, high grade right hand panel
 |
Paget's Disease
Paget's disease of the nipple
 |
Microinvasion
- Microinvasion is uncommon and usually seen in association with high grade or comedo DCIS
- To qualify as microinvasive it is necessary:
- To demonstrate carcinoma cells outside the specialised periductal stroma
- That the size of each such focus is < 1mm
- Microinvasive carcinoma cells are distributed singly and when in small groups have an irregular outline
- The presence of periductal chronic inflammation and fibrosis is often a pointer to lurking microinvasive cells
- Immunostains are helpful both in detection and confirmation of microinvasion:
- A pan cytokeratin marker helps to pick out the cells as irregular groups or single cells - they can be very subtle on an H & E
- A myoepithelial marker such as CK 5/6 will demonstrate the absence of such a layer around the suspect cells
- If you are cutting levels to pursue a suspect focus ask for any immunostains either before the levels or between them depending on whether you have already reached the suspicious focus or alternatively are not quite there
High grade comedo DCIS and microinvasion - 'Mouse over' for high power view
 |
High grade DCIS and microinvasion (example 2)
 |
High grade DCIS and microinvasion (example 2) CK 5/6 immunostain
Note the foci of microinvasive carcinoma (labels A & B) and the apparent breach of the basal layer with protruding carcinoma into specialised stroma (arrow)
 |
Assessing receptor status in DCIS
- A number of trials are underway evaluating the role of endocrine therapy in DCIS
- Knowledge of oestrogen receptor (ER) status is a requirement for entry
- In a retrospective review of cases from the NSABP B24 Trial 1 Allred showed that >10% of DCIS tumour cells show positive staining for ER predicted response to Tamoxifen in preventing adverse events following conservation surgery and radiotherapy for DCIS
- The UK IBIS II and DCIS II trials stipulate <5% staining as a cut-off point
- The current UK NHSBSP recommended cut-off point is <5%
Comparison between negative (<5% of cells staining) and strongly positive staining for ER in two cases of DCIS
 |
 |
References: